IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0160313.html
   My bibliography  Save this article

Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

Author

Listed:
  • O Fernández
  • R Arroyo
  • S Martínez-Yélamos
  • M Marco
  • J A García Merino
  • D Muñoz
  • E Merino
  • A Roque
  • RELOAD Study Group

Abstract

The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart® electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) β-1a (Rebif®). The aim of the study was to determine long-term adherence to this treatment in patients with relapsing-remitting multiple sclerosis (RRMS). This retrospective multicentre observational study analysed 258 patients with RRMS who were receiving sc IFN β-1a (Rebif®) treatment by using RebiSmart® until replacement (36 months maximum lifetime) or treatment discontinuation. Adherence was calculated with data (injection dosage, time, and date) automatically recorded by RebiSmart®. Patients in the study had a mean age of 41 years with a female proportion of 68%. Mean EDSS score at start of treatment was 1.8 (95% CI, 1.6–1.9). Overall adherence was 92.6% (95% CI, 90.6–94.5%). A total of 30.2% of patients achieved an adherence rate of 100%, 80.6% at least 90%, and only 13.2% of patients showed a suboptimal adherence (

Suggested Citation

  • O Fernández & R Arroyo & S Martínez-Yélamos & M Marco & J A García Merino & D Muñoz & E Merino & A Roque & RELOAD Study Group, 2016. "Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-12, August.
  • Handle: RePEc:plo:pone00:0160313
    DOI: 10.1371/journal.pone.0160313
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160313
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0160313&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0160313?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Oscar Fernández & Javier Agüera & Guillermo Izquierdo & Javier Millán-Pascual & Lluis Ramió i Torrentà & Pedro Oliva & Javier Argente & Yasmina Berdei & Jose Maria Soler & Olga Carmona & Jose Maria Er, 2012. "Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain," PLOS ONE, Public Library of Science, vol. 7(5), pages 1-7, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0160313. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.